USPlabs LLC Announces a Recall of OxyElite Pro Dietary Supplements Due to Possible Health Risk

DALLAS, Nov. 9, 2013 /PRNewswire-USNewswire/ -- USPlabs LLC, Dallas, TX is voluntarily conducting a national recall of all lots and sizes of the OxyElite Pro dietary supplement products listed below. These products contain Aegeline, a synthesized version of a natural extract from the Bael tree.

Epidemiological evidence shows that use of these products has been associated with serious adverse health consequences, namely serious liver damage or acute liver failure, concentrated in Hawaii. Investigations are ongoing into a potential causal relationship. The Company agrees with FDA that a national recall is appropriate as a precautionary measure.

Product was distributed nationwide through retail stores, mail orders and direct delivery.

OxyElite Pro Super Thermo capsules

• 2 count capsules UPC #094922417275
• 10 count capsules UPC #094922417251
• 10 count capsules UPC #094922417268
• 21 count capsules UPC #094922426604
• 90 count capsules UPC #094922395573
• 90 count capsules "Pink label" UPC #094922447906
• 180 count capsules UPC #094922447852
  

OxyElite Pro Ultra-Intense Thermo capsules

• 3 count capsules UPC #094922447883
• 3 count capsules UPC #094922447876
• 90 count capsules UPC #094922395627
• 180 count capsules UPC #094922447869

OxyElite Pro Super Thermo Powder

• Fruit Punch 0.15 oz UPC #094922417237
• Fruit Punch 0.15 oz UPC #094922447517
• Fruit Punch 4.6 oz UPC #094922426369
• Fruit Punch 5 oz UPC #094922447487
• Blue Raspberry 4.6 oz UPC #094922426376
• Grape Bubblegum 4.6 oz UPC #094922447500
• Green Apple 4.6 oz UPC #094922426499
  

No other products produced by USPlabs are subject to recall. Consumers who have purchased the products should immediately discontinue use of the product and return it to where they purchased it for a refund. Contact your health care professional if you have experienced any adverse effects.
Consumers can contact USPlabs at 1(800) 890-3067 (Monday-Friday, 9 am - 5 pm EST) or [email protected]. Adverse reactions may be reported to the FDA MedWatch Adverse Event Reporting program online at http://www.fda.gov/medwatch/getforms.htm, by regular mail, or by FDA's MedWatch Hotline 1-800-FDA-1088.

SOURCE USPlabs